SEARCH

COVID: ASTRAZENECA R&D EXEC PANGALOS SAYS DATA SO FAR SHOWS THAT 8-12 WEEK INTERVAL TO 2ND DOSE IS SWEET SPOT FOR EFFICACY

13 Jan 2021 / 18:39 H.

    COVID: ASTRAZENECA R&D EXEC PANGALOS SAYS DATA SO FAR SHOWS THAT 8-12 WEEK INTERVAL TO 2ND DOSE IS SWEET SPOT FOR EFFICACY

    email blast